InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Chanda Sanjay. Director active across 1 company, notably AN2 Therapeutics, Inc.. Cumulatively, 4 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €4k. History available since 15 March 2024. The latest transaction was disclosed on 26 February 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
4 of 4 declarations